Hospital
Alameda Health System
Alameda Health System was paid $5.26M by Medicaid between Jan 2018 and Dec 2024, across 175 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.
33Billing provider infoALAMEDA HEALTH SYSTEM
OAKLAND, CA 94602
OAKLAND, CA 94602
33aNPI1083815872assigned 05/30/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.26M
24GClaims195,232
24DCodes billed175
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#222 of 410
Median peer was paid$6.90M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,500 | $490K | |
| 2019 | 21,676 | $320K | |
| 2020 | 10,240 | $241K | |
| 2021 | 28,176 | $721K | |
| 2022 | 25,281 | $655K | |
| 2023 | 35,998 | $1.46M | |
| 2024incomplete | 46,361 | $1.37M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 14,788 | 12,531 | $1.05M |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 6.3% | 7,320 | 6,451 | $329K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 5.5% | 36,339 | 5,935 | $291K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.4% | 1,541 | 1,523 | $234K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.2% | 606 | 577 | $221K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.1% | 1,895 | 1,846 | $215K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.0% | 2,471 | 2,265 | $211K |
| 0681 | 3.9% | 38 | 38 | $205K | |
| 99070 | 3.8% | 801 | 609 | $199K | |
| 0250 | 3.8% | 16,745 | 5,899 | $199K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.5% | 9,960 | 8,304 | $133K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2.4% | 818 | 815 | $129K |
163 more codes
| 71045 | Radiologic examination, chest; single view | 2.2% | 3,412 | $115K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 1,210 | $97K |
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 2,826 | $81K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.5% | 1,379 | $80K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 10,669 | $76K |
| 93308 | 1.4% | 782 | $74K | |
| 84484 | 1.4% | 5,011 | $73K | |
| 99199 | Unlisted special service, procedure or report | 1.4% | 754 | $72K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 1,862 | $69K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.0% | 1,053 | $54K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.0% | 534 | $53K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,045 | $44K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,390 | $43K |
| 80053 | Comprehensive metabolic panel | <1% | 1,709 | $40K |
| 83690 | <1% | 2,791 | $39K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,421 | $37K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 496 | $37K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,994 | $35K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,998 | $31K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,584 | $28K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 740 | $25K |
| 82962 | <1% | 2,068 | $24K | |
| 71250 | <1% | 426 | $23K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 396 | $23K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 720 | $21K |
| J3490 | Unclassified drugs | <1% | 611 | $19K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 919 | $19K |
| 83605 | <1% | 1,308 | $18K | |
| 81003 | <1% | 3,935 | $18K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,181 | $18K |
| 90837 | Psychotherapy session, about an hour | <1% | 382 | $17K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 519 | $16K |
| 99283 | Emergency room visit (moderate) | <1% | 377 | $16K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 519 | $16K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 108 | $15K |
| 86703 | <1% | 1,109 | $14K | |
| 94060 | <1% | 117 | $14K | |
| 85027 | <1% | 2,092 | $14K | |
| 73030 | <1% | 636 | $13K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,022 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,243 | $13K |
| 86803 | <1% | 1,865 | $13K | |
| 70498 | <1% | 27 | $12K | |
| 86900 | <1% | 544 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 566 | $11K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 235 | $10K |
| 92553 | <1% | 199 | $10K | |
| 73562 | <1% | 428 | $8K | |
| 70496 | <1% | 27 | $8K | |
| 76770 | <1% | 125 | $8K | |
| 73630 | <1% | 446 | $8K | |
| 0450 | Emergency room services | <1% | 249 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 487 | $7K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,738 | $7K |
| 93971 | <1% | 87 | $6K | |
| 73502 | <1% | 282 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 748 | $6K |
| 80061 | Lipid panel | <1% | 396 | $6K |
| 87088 | <1% | 1,717 | $6K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 85 | $6K |
| 85610 | <1% | 1,569 | $5K | |
| 73564 | <1% | 176 | $5K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 186 | $5K |
| 83880 | <1% | 380 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $5K |
| 73110 | <1% | 212 | $5K | |
| 87490 | <1% | 250 | $4K | |
| 91200 | <1% | 108 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,687 | $4K |
| 86850 | <1% | 542 | $4K | |
| 73560 | <1% | 167 | $4K | |
| 87590 | <1% | 250 | $4K | |
| 72100 | <1% | 145 | $4K | |
| 81001 | <1% | 1,423 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 834 | $4K |
| 86901 | <1% | 544 | $4K | |
| 76604 | <1% | 147 | $3K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 81 | $3K |
| 82803 | <1% | 141 | $3K | |
| J1815 | Injection, insulin, per 5 units | <1% | 76 | $3K |
| 73610 | <1% | 154 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 58 | $3K |
| 72170 | <1% | 163 | $3K | |
| 96415 | <1% | 76 | $3K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 113 | $3K |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 34 | $2K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 236 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 149 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,455 | $2K |
| 81025 | <1% | 304 | $2K | |
| 93970 | <1% | 26 | $2K | |
| 73130 | <1% | 115 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 86 | $2K |
| 87341 | <1% | 292 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 13 | $2K |
| 86480 | <1% | 35 | $2K | |
| 87040 | <1% | 240 | $2K | |
| 93017 | <1% | 96 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 876 | $2K |
| 77066 | Tomosynthesis, mammo | <1% | 53 | $1K |
| 84439 | <1% | 119 | $1K | |
| 90686 | <1% | 162 | $1K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 25 | $1K |
| 86140 | <1% | 307 | $1K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $1K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 386 | $1K |
| 93925 | <1% | 12 | $905.91 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 83 | $865.45 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 49 | $853.57 |
| 87077 | <1% | 160 | $851.77 | |
| 94618 | <1% | 60 | $847.69 | |
| 94729 | <1% | 104 | $684.39 | |
| 85379 | <1% | 64 | $665.95 | |
| 84100 | <1% | 26 | $663.05 | |
| 93289 | <1% | 36 | $649.51 | |
| 82043 | <1% | 86 | $554.34 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 13 | $539.63 |
| 94726 | <1% | 54 | $538.16 | |
| 93922 | <1% | 57 | $492.61 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 246 | $480.08 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 103 | $473.44 |
| 82274 | <1% | 27 | $439.60 | |
| 85652 | <1% | 161 | $422.92 | |
| 87186 | <1% | 177 | $381.03 | |
| 36593 | <1% | 13 | $378.88 | |
| 82565 | <1% | 80 | $358.45 | |
| 76642 | <1% | 14 | $337.67 | |
| 73590 | <1% | 27 | $320.36 | |
| 82040 | <1% | 26 | $319.37 | |
| 82607 | <1% | 64 | $270.76 | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 29 | $258.46 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 118 | $210.46 |
| 73552 | <1% | 15 | $166.47 | |
| 73080 | <1% | 15 | $161.46 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 118 | $154.83 |
| 82550 | <1% | 49 | $132.33 | |
| 86706 | <1% | 28 | $118.75 | |
| 82310 | <1% | 40 | $112.34 | |
| 82247 | <1% | 41 | $109.93 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 117 | $104.02 |
| 82728 | <1% | 15 | $101.08 | |
| 84460 | <1% | 68 | $99.11 | |
| 84466 | <1% | 14 | $82.80 | |
| 83540 | <1% | 15 | $78.99 | |
| 11721 | <1% | 15 | $53.14 | |
| 94760 | <1% | 78 | $46.93 | |
| G0008 | Administration of influenza virus vaccine | <1% | 71 | $36.78 |
| 82947 | <1% | 44 | $23.08 | |
| 84145 | <1% | 12 | $22.21 | |
| 84295 | <1% | 40 | $8.32 | |
| 87081 | <1% | 44 | $5.68 | |
| 84075 | <1% | 36 | $5.18 | |
| 82374 | <1% | 38 | $4.88 | |
| 84520 | <1% | 39 | $3.95 | |
| 90688 | <1% | 29 | $0.04 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 13 | $0.00 |
| 0250R | 0% | 355 | $0.00 | |
| G0410 | Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes | 0% | 2,420 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 82 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 15 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 12 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 16 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, SHARI (VP REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Alameda Health System | Alameda, CA | $11.52M |
| Alameda Health System | Oakland, CA | $1.72M |
| Alameda Health System | San Leandro, CA | $1.39M |
| Elevate 4:14 LLC | Greeley, CO | $158K |
| Alameda Health System | San Leandro, CA | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.